Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10068385 | 0.83 | PLA2G10 (0.31) | PLA2G10PLA2G5 | |
| SCHEMBL16330283 | 0.81 | PLA2G10 (0.30) | PLA2G10PLA2G5 | |
| SCHEMBL12222183 | 0.80 | — | — | |
| SCHEMBL12708629 | 0.79 | — | — | |
| SCHEMBL12222273 | 0.79 | — | — | |
| SCHEMBL15251859 | 0.78 | SMN1; SMN2 (0.34) | KMT2A | |
| SCHEMBL3799622 | 0.77 | PLA2G10 (0.41) | CACNA1HPLA2G10PLA2G5KMT2A | |
| SCHEMBL27147241 | 0.77 | PLA2G10 (0.41) | CACNA1HPLA2G10PLA2G5KMT2A | |
| SCHEMBL3470166 | 0.77 | PLA2G10 (0.41) | CACNA1HPLA2G10PLA2G5KMT2A | |
| SCHEMBL10068392 | 0.77 | CYP4F2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1904460-B1 | MULTIDENTATE AZA LIGANDS ABLE TO COMPLEX METAL IONS AND THE USE THEREOF IN DIAGNOSTICS AND THERAPY | BRACCO IMAGING SPA (IT) | 2012-05-16 | — | — | EP | disclosed |
| US-8105567-B2 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING SPA (IT) | 2012-01-31 | — | — | US | disclosed |
| EP-1803711-B1 | Process for the preparation of multidentate aza ligands able to complex metal ions | BRACCO IMAGING SPA (IT) | 2011-10-19 | — | — | EP | disclosed |
| US-20110082280-A1 | Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules | BRACCO IMAGING S.P.A. (IT) | 2011-04-07 | — | — | US | disclosed |
| US-7893223-B2 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING S.P.A. (IT) | 2011-02-22 | — | — | US | disclosed |
| US-20100069628-A1 | Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy | BRACCO IMAGING S.P.A (IT) | 2010-03-18 | — | — | US | disclosed |
| EP-1803711-A1 | Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING S.p.A. (IT) | 2007-07-04 | — | — | EP | disclosed |
| EP-1417183-B1 | MULTIDENTATE AZA LIGANDS ABLE TO COMPLEX METAL IONS AND THE USE THEREOF IN DIAGNOSTICS AND THERAPY | BRACCO IMAGING SPA (IT) | 2007-05-23 | — | — | EP | disclosed |
| US-7186400-B2 | Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING S.P.A. (IT) | 2007-03-06 | — | — | US | disclosed |
| US-20060034773-A1 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | BRACCO IMAGING SPA (IT) | 2006-02-16 | — | — | US | disclosed |
| US-20040156786-A1 | Multidentate aza ligands able to complex metal ions and the use therof in diagnostics and therapy | BRACCO IMAGING S.P.A. (IT) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060034773-A1 | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy | SSTR3, MB, CA13 | CACNA1H 1254/4885PLA2G10 3972/4885PLA2G5 2718/4885 |
| US-20110082280-A1 | Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules | CD99, CD209, PRMT9 | CACNA1H 2824/4885PLA2G10 4528/4885PLA2G5 2873/4885 |
| US-20040156786-A1 | Multidentate aza ligands able to complex metal ions and the use therof in diagnostics and therapy | SSTR1, SSTR3, TFRC | CACNA1H 2080/4885PLA2G10 4746/4885PLA2G5 4751/4885 |
| US-20100069628-A1 | Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy | CD99, MB, HBZ | CACNA1H 1062/4885PLA2G10 4838/4885PLA2G5 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.